Cumberland Pharmaceuticals Inc. Disposal Group, Including Discontinued Operation, Assets, Current
Cumberland Pharmaceuticals Inc. (CPIX) had Disposal Group, Including Discontinued Operation, Assets, Current of $15.65 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2026-08-07
- 2026-06-30: Disposal Group, Including Discontinued Operation, Assets, Current $15.65M.
- 2025-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $7.99M.
- 2020-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $0.00.
- 2020-09-30: Disposal Group, Including Discontinued Operation, Assets, Current $727.67K.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current | Disposal Group, Including Discontinued Operation, Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $15.65M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $7.99M 10-Q · filed 2026-08-07 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2020-09-30 | $727.67K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $744.40K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.29M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $2.46M 10-K · filed 2021-03-12 | $2.48M 10-Q · filed 2020-05-22 |
| 2018-12-31 | $3.71M 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |